British American Tobacco PLC – Corporate and Financial Developments
British American Tobacco plc (BTI), a London‑listed consumer‑staples company, reported a series of significant events on 30 October 2025 that impact both its operational strategy and financial performance.
Share‑Based Transactions
On 30 October 2025 the company announced a transaction involving its own shares, executed in accordance with the regulatory framework governing share repurchases. The announcement was released on the company’s investor‑relations portal and referenced the company’s legal identifiers: registration number 03407696, short name BATS, share code BTI, and ISIN GB0002875804.
U.S. Vape Rollout Suspension
Earlier in the day, BTI suspended the rollout of its U.S. vape product line. The decision followed intensified regulatory scrutiny in the United States, prompting the company to reassess the commercial viability of its Vuse brand within the U.S. market.
Third‑Quarter 2025 Financial Results
For the fiscal third quarter ending 30 October 2025, BTI disclosed the following:
| Metric | 2025 Q3 | 2024 Q3 | % Change |
|---|---|---|---|
| Net profit | 702 000 MYR | 6 790 000 MYR | –89.66 % |
| Revenue | 300 800 000 MYR | 699 400 000 MYR | –50.68 % |
The sharp decline in profitability and revenue is attributed to multiple regulatory measures, including the implementation of a new health‑warning graphic on cigarette packaging and a retail display ban. The company also reported that it was gradually divesting its Vuse electronic‑smoking business, which contributed to a 21 % reduction in total shipments.
Despite the downturn, BTI maintained its interim dividend policy, announcing a third‑quarter dividend of 5 sen per share with an ex‑dividend date of 13 November. Management highlighted that the core cigarette business, particularly the Dunhill brand, continued to hold market share and that cost‑management measures had preserved net‑profitability within the remaining portfolio.
Share Price and Market Position
- Close price (28 Oct 2025): 3 920 GBX
- 52‑week high: 4 401 GBX (20 Aug 2025)
- 52‑week low: 2 699 GBX (3 Nov 2024)
- Market capitalization: 85.68 billion GBX
- Price‑earnings ratio: 28.59
The share price remained within the 52‑week range, reflecting market uncertainty amid regulatory challenges but also the company’s ability to sustain dividends.
Strategic Outlook
In its quarterly presentation, BTI’s management reiterated a focus on strengthening its core product lines, optimizing the product mix, and driving operational efficiencies. The company stated that it would continue to monitor regulatory developments closely, particularly in the U.S. and European markets, and would adjust its product offerings accordingly.
All figures are taken from the company’s official announcements and public filings dated 30 October 2025.